Abstract
Prior authorizations (PAs) are a means by which insurance companies ostensibly regulate the overutilization of costly medications and medical services. While controlling health care costs is an important consideration, PAs are increasingly criticized for the administrative burdens placed on health care practices and providers, with resultant delays in patient care and the potential for harm when patients are unable to get their indicated treatments/services. Acknowledging these criticisms while balancing the need for prudent resource management, a consensus statement for improving the PA process was put out in 2018 by the American Medical Association (AMA), American Hospital Association, America's Health Insurance Plans, the American Pharmacists Association, Blue Cross Blue Shield Association, and the Medical Group Management Association emphasizing the need for reform.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
